ZA915698B - Sucralfate chewable tablet - Google Patents

Sucralfate chewable tablet

Info

Publication number
ZA915698B
ZA915698B ZA915698A ZA915698A ZA915698B ZA 915698 B ZA915698 B ZA 915698B ZA 915698 A ZA915698 A ZA 915698A ZA 915698 A ZA915698 A ZA 915698A ZA 915698 B ZA915698 B ZA 915698B
Authority
ZA
South Africa
Prior art keywords
sugar
gel former
chewable tablet
sucralphate
sweetener
Prior art date
Application number
ZA915698A
Other languages
English (en)
Inventor
Hans Peter Weckenmann
Peter Weckenmann Hans
Hans-Guenther Schwamb
Schwamb Hans-Guenther
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA915698B publication Critical patent/ZA915698B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA915698A 1990-07-19 1991-07-19 Sucralfate chewable tablet ZA915698B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4022944A DE4022944A1 (de) 1990-07-19 1990-07-19 Sucralfat-kautablette

Publications (1)

Publication Number Publication Date
ZA915698B true ZA915698B (en) 1992-05-27

Family

ID=6410578

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915698A ZA915698B (en) 1990-07-19 1991-07-19 Sucralfate chewable tablet

Country Status (20)

Country Link
US (1) US5648092A (fr)
EP (1) EP0471967B1 (fr)
JP (1) JPH04234324A (fr)
KR (1) KR0181955B1 (fr)
AT (1) ATE137117T1 (fr)
AU (1) AU646474B2 (fr)
CA (1) CA2046843A1 (fr)
CZ (1) CZ280566B6 (fr)
DE (2) DE4022944A1 (fr)
DK (1) DK0471967T3 (fr)
ES (1) ES2088445T3 (fr)
FI (1) FI98702C (fr)
GR (1) GR3020228T3 (fr)
HU (1) HU208488B (fr)
IE (1) IE73252B1 (fr)
MX (1) MX9100246A (fr)
PT (1) PT98311B (fr)
SK (1) SK279206B6 (fr)
TW (1) TW198691B (fr)
ZA (1) ZA915698B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173183T3 (es) * 1994-04-26 2002-10-16 Chugai Pharmaceutical Co Ltd Procedimiento de preparacion de sucralfato granulado y fundido.
WO1996023507A1 (fr) * 1995-02-02 1996-08-08 Chugai Seiyaku Kabushiki Kaisha Preparation de sucralfate
TW469135B (en) * 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
EP0918513B1 (fr) * 1996-08-15 2000-12-06 Losan Pharma GmbH Medicament a administration orale facile a avaler
EP0890358B1 (fr) * 1997-07-10 2005-02-09 Dr. Gergely & Co. Comprimé à macher soluble, dragéifié, contenant des gommes
DE19758100B4 (de) * 1997-12-18 2006-05-04 Lichtwer Pharma Ag Verfahren zum Herstellen von Pflanzenextrakt enthaltenden pharmazeutischen Formulierungen
WO1999033445A1 (fr) * 1997-12-29 1999-07-08 The Procter & Gamble Company Composition de comprime
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
AU5086799A (en) * 1999-06-30 2001-01-22 Procter & Gamble Company, The Personal hygiene tablet composition
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
AUPS244002A0 (en) 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US9028882B2 (en) 2005-05-02 2015-05-12 4Life Patents, Llc Nutraceutical gels
TWI380821B (zh) * 2005-05-02 2013-01-01 4Life Patents Llc 轉移因子製備物及相關的方法
FR2927808B1 (fr) * 2008-02-26 2011-04-29 Fabre Pierre Dermo Cosmetique Gel de sucralfate sterilise
JP7390695B2 (ja) * 2017-02-03 2023-12-04 株式会社東洋新薬 錠剤及び錠剤の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
DE3430809A1 (de) * 1984-08-22 1986-03-06 Merck Patent Gmbh, 6100 Darmstadt Sucralfat-suspension
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
US4910023A (en) * 1988-06-09 1990-03-20 Warner-Lambert Company Drug in combination with flavor masking agent and method for making same
US4990610A (en) * 1988-08-25 1991-02-05 Applied Analytical Industries, Inc. Method for preparing high potency sucralfate
US4975281A (en) * 1989-01-30 1990-12-04 E. R. Squibb & Sons, Inc. Anti-ulcer composition
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same

Also Published As

Publication number Publication date
AU8046291A (en) 1992-01-23
CA2046843A1 (fr) 1992-01-20
HU912431D0 (en) 1991-12-30
CZ280566B6 (cs) 1996-02-14
DE59107709D1 (de) 1996-05-30
HUT63056A (en) 1993-07-28
EP0471967B1 (fr) 1996-04-24
FI98702B (fi) 1997-04-30
HU208488B (en) 1993-11-29
JPH04234324A (ja) 1992-08-24
CS224191A3 (en) 1992-02-19
IE73252B1 (en) 1997-05-21
DE4022944A1 (de) 1992-01-23
FI913479A (fi) 1992-01-20
GR3020228T3 (en) 1996-09-30
US5648092A (en) 1997-07-15
FI98702C (fi) 1997-08-11
KR0181955B1 (ko) 1999-05-01
MX9100246A (es) 1992-02-28
SK279206B6 (sk) 1998-08-05
ATE137117T1 (de) 1996-05-15
DK0471967T3 (da) 1996-08-05
PT98311A (pt) 1992-05-29
PT98311B (pt) 1999-01-29
FI913479A0 (fi) 1991-07-18
IE912531A1 (en) 1992-01-29
ES2088445T3 (es) 1996-08-16
AU646474B2 (en) 1994-02-24
KR920002155A (ko) 1992-02-28
TW198691B (fr) 1993-01-21
EP0471967A1 (fr) 1992-02-26

Similar Documents

Publication Publication Date Title
ZA915698B (en) Sucralfate chewable tablet
EP0306454A3 (fr) Comprimés possédant une bioadhésion aux membranes muqueuses
AU7848187A (en) Pharmaceutical formulations
SE8702940D0 (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
IL81201A (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
AU7084587A (en) Methylprednisolone/sodium carboxymethyl starch tablet composition
IT1217445B (it) Composizione farmaceutiche orosolubili contenti acetilcisteina
DE69815856D1 (de) Cefadroxilmonohydrat tablettenformulierung
IT8819340A0 (it) Procedimento di gassificazione per ottenere canditi gassificati.
CA2106216A1 (fr) Compositions anti-acides a macher
AU2228888A (en) Aqueous pharmaceutical preparation for oral administration
SE8703632D0 (sv) Sustained release fluoride composition
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
AR244243A1 (es) Procedimiento para preparar timolinfotropina.
ATE227519T1 (de) Kalziumreiche gelierte paste ohne zucker
AU6001790A (en) Formulations of phenytoin sodium for intravenous administration
NZ215654A (en) Non-sticking chewing gum containing hydrogenated starch, hydrolysate and carboxymethyl cellulose
IL85252A0 (en) Pilocarpine derivatives,their production and pharmaceutical compositions containing them
EP0351542A3 (en) Xylite and sugar-free chewing tablet
AU4016189A (en) Use of 2-azabicyclo(2.2.2) octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation
EP0356254A3 (fr) Formulations pharmaceutiques
IT1274249B (it) Formulazioni farmaceutiche a base di carbossimetilcisteina sale di lisina
DK493887A (da) Buccal formulering
IL88797A (en) 4-demethyl- epipodophyllotoxin glucose 4(-carboxyl ester, carbonate and carbamate derivatives and pharmaceutical compositions containing them
GB8904176D0 (en) Effervescent tablet formulations of sodium thiosulphate